Work

Nemtabrutinib, a Noncovalent Reversible BTK Inhibitor in Relapsed or Refractory Marginal Zone Lymphoma: Results from the Phase 2 Bellwave-003 Study

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-201646

Authors: Pier Luigi Zinzani, Juan Carlos Dupont, Alessandra Tucci, Jing Yang, Yan Xu, Siyang Leng, Muhit Ozcan

Institutions: Istituto di Ematologia di Bologna, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno, Merck & Co., Inc., Rahway, NJ, USA (United States), Ankara University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405039137

Cites:

Cited by: 1

Related to: 10